CarolinaEast Oncology and Hematology Associates
New Bern, North Carolina, United States
Cancer treatment center in New Bern, North Carolina
1300 Health Dr, New Bern, NC 28560
About CarolinaEast Oncology and Hematology Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CarolinaEast Oncology and Hematology Associates
During the past decade, CarolinaEast Oncology and Hematology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
2003-05-01
Completed
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
2004-08-18
Completed
144
Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery
2000-02-23
2013-01-31
Completed
815
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CarolinaEast Oncology and Hematology Associates"
#1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at CarolinaEast Oncology and Hematology Associates
According to Clinical.Site data, the most researched conditions in "CarolinaEast Oncology and Hematology Associates" are
"Estrogen Receptor-positive Breast Cancer" (1 trials), "HER2/Neu Negative" (1 trials), "Malignant Neoplasm" (1 trials), "Stage I Colon Cancer AJCC v8" (1 trials) and "Stage I Rectal Cancer AJCC v8" (1 trials). Many other conditions were trialed in "CarolinaEast Oncology and Hematology Associates" in a lesser frequency.
Clinical Trials Intervention Types at CarolinaEast Oncology and Hematology Associates
Most popular intervention types in "CarolinaEast Oncology and Hematology Associates" are "Other" (3 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (2 trials), "Questionnaire Administration" (2 trials), "Dexamethasone" (1 trials), "Fosaprepitant Dimeglumine" (1 trials) and "Fulvestrant" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CarolinaEast Oncology and Hematology Associates
The vast majority of trials in "CarolinaEast Oncology and Hematology Associates" are
3 trials for "All" genders.
Clinical Trials Status at CarolinaEast Oncology and Hematology Associates
Currently, there are NaN active trials in "CarolinaEast Oncology and Hematology Associates".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in CarolinaEast Oncology and Hematology Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CarolinaEast Oncology and Hematology Associates, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".